Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Annika Andersson Sjoland (Lund, Sweden), Annika Andersson Sjoland, Anna-Karin Larsson Callerfelt, Lena Thiman, Oskar Hallgren, Ingrid Skog, Lennart Hansson, Leif Eriksson, Leif Bjermer, Gunilla Westergren-Thorsson. Prostacyclin and VEGF in the rejection process after lung transplantation – A possible biomarker. Eur Respir J 2016; 48: Suppl. 60, 4040

Member's Comments

No comment yet.

Related content which might interest you: Elevated levels of prostacyclin and VEGF in the rejection process after lung transplantation Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction Year: 2013 Fibrocyte involvement and increased prostacyclin and VEGF in the rejection process after lung transplantation Source: International Congress 2014 – Lung cell biology in injury and repair Year: 2014 Does perfusion with the organ care system influence inflammatory response in lung transplantation? Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Altered extracellular matrix in transplanted lungs as a potential marker for chronic rejection Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Inflammatory response following DCD and DBD lung transplantation Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms Year: 2016 Utility of C4d by immunohistochemistry for the diagnosis of antibody-mediated rejection in lung transplantation Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Analysis of factors affecting pretransplant pulmonary function tests and impact on overall survival after allogenic stem cell transplantation Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015 Serum cytokines patterns in lung transplant recipients Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015 Differential VEGF signalling in the lung Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Marginated monocytes play a central role in lung ischaemia–reperfusion injury in mice: Implications for lung transplantation Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 Lung tissue bioengineering for transplantation and modelling of development, disease and regeneration Source: Eur Respir Monogr 2021; 91: 248-272 Year: 2021 Epithelial-mesenchymal transition in chronic lung allograft dysfunction. Role of leucocyte microparticles Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms Year: 2016 Prevention of ischemia-reperfusion lung injury by supplementation of the preservation solution with an oxygen carrier in porcine lung transplant model Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 A new biomarker for chronic lung allograft dysfunction Source: International Congress 2014 – Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes Year: 2014 NFkB location in T-cells is promising to monitor immunosuppression after lung transplantation Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 Mechanisms and biomarkers of ischaemia-reperfusion-induced lung injury in lung transplantation Source: Annual Congress 2004 - Mechanisms and biomarkers of ischaemia-reperfusion-induced lung injury: lessons learnt from lung transplantation Year: 2004 Pirfenidone stabilizes pulmonary function and reduces 18F-FDG-uptake in restrictive allograft syndrome following lung transplantation Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 Pulmonary veno-occlusive disease after hematopoietic stem cell transplantation Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 A potential role for endothelial adhesion molecules and cytokines in chemotherapy-induced lung fibrosis Source: International Congress 2014 – Cell biology 2014 Year: 2014 Blood mRNA and miRNA transcriptome to predict chronic lung allograft dysfunction Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015